Pheneturide

Pheneturide
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	N03AX13 (WHO) ;
Identifiers
	IUPAC name (RS)-N-Carbamoyl-2-phenyl-butanamide;
CAS Number	90-49-3 ;
PubChem CID	72060;
ChemSpider	65046 ;
UNII	878CEJ4HGX;
KEGG	D01190 ;
CompTox Dashboard (EPA)	DTXSID4020612 ;
ECHA InfoCard	100.001.817
Chemical and physical data
Formula	C11H14N2O2
Molar mass	206.245 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES O=C(N)NC(=O)C(c1ccccc1)CC;
	InChI InChI=1S/C11H14N2O2/c1-2-9(10(14)13-11(12)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H3,12,13,14,15) ; Key:AJOQSQHYDOFIOX-UHFFFAOYSA-N ;
	(what is this?) (verify)

Pheneturide (INN, BAN) (brand names Benuride, Deturid, Pheneturid, Septotence, Trinuride),^[1] also known as phenylethylacetylurea (or ethylphenacemide), is an anticonvulsant of the ureide class.^[2]^[3] Conceptually, it can be formed in the body as a metabolic degradation product from phenobarbital. It is considered to be obsolete^[4] and is now seldom used.^[5] It is marketed in Europe, including in Poland, Spain and the United Kingdom.^[6] Pheneturide has a similar profile of anticonvulsant activity and toxicity relative to phenacemide.^[7]^[8] As such, it is only used in cases of severe epilepsy when other, less-toxic drugs have failed.^[8] Pheneturide inhibits the metabolism and thus increases the levels of other anticonvulsants, such as phenytoin.^[5]^[6]

References

^ Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 998–. ISBN 978-3-7692-2114-5.
^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 959–. ISBN 978-1-4757-2085-3.
^ Byrne B, Rothchild R (1999). "1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: applications to the anticonvulsant pheneturide". Chirality. 11 (7): 529–35. doi:10.1002/(SICI)1520-636X(1999)11:7<529::AID-CHIR3>3.0.CO;2-K. PMID 10423278.
^ Levy RH (2002). Antiepileptic Drugs. Lippincott Williams & Wilkins. pp. 210–. ISBN 978-0-7817-2321-3.
^ ^a ^b Denham MJ (6 December 2012). The Treatment of Medical Problems in the Elderly. Springer Science & Business Media. pp. 335–. ISBN 978-94-011-6223-4.
^ ^a ^b Vida J (19 July 2013). Anticonvulsants. Elsevier. pp. 4, 42. ISBN 978-0-323-14395-0.
^ deStevens G, Zingel V, Leschke C, Hoeprich PD, Schultz RM, Mehrotra PK, Batra S, Bhaduri AP, Saxena AK, Saxena M, eds. (11 November 2013). Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques. Basel: Birkhäuser. pp. 217–. ISBN 978-3-0348-7161-7. Retrieved 3 September 2016.
^ ^a ^b Lancaster R (22 October 2013). Pharmacology in Clinical Practice. Elsevier. pp. 222–. ISBN 978-1-4831-9294-9.

This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it.

[Muller1998-1] Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 998–. ISBN 978-3-7692-2114-5.

[Elks2014-2] Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 959–. ISBN 978-1-4757-2085-3.

[pmid10423278-3] Byrne B, Rothchild R (1999). "1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: applications to the anticonvulsant pheneturide". Chirality. 11 (7): 529–35. doi:10.1002/(SICI)1520-636X(1999)11:7<529::AID-CHIR3>3.0.CO;2-K. PMID 10423278.

[Levy2002-4] Levy RH (2002). Antiepileptic Drugs. Lippincott Williams & Wilkins. pp. 210–. ISBN 978-0-7817-2321-3.

[Denham2012-5] Denham MJ (6 December 2012). The Treatment of Medical Problems in the Elderly. Springer Science & Business Media. pp. 335–. ISBN 978-94-011-6223-4.

[Vida2013-6] Vida J (19 July 2013). Anticonvulsants. Elsevier. pp. 4, 42. ISBN 978-0-323-14395-0.

[deStevensZingel2013-7] Stevens G, Zingel V, Leschke C, Hoeprich PD, Schultz RM, Mehrotra PK, Batra S, Bhaduri AP, Saxena AK, Saxena M, eds. (11 November 2013). Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques. Basel: Birkhäuser. pp. 217–. ISBN 978-3-0348-7161-7. Retrieved 3 September 2016.

[Lancaster2013-8] Lancaster R (22 October 2013). Pharmacology in Clinical Practice. Elsevier. pp. 222–. ISBN 978-1-4831-9294-9.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

See also

References